DK0858345T3 - Anvendelse af muteiner af vildtypecytokiner som immunogener - Google Patents

Anvendelse af muteiner af vildtypecytokiner som immunogener

Info

Publication number
DK0858345T3
DK0858345T3 DK96930345T DK96930345T DK0858345T3 DK 0858345 T3 DK0858345 T3 DK 0858345T3 DK 96930345 T DK96930345 T DK 96930345T DK 96930345 T DK96930345 T DK 96930345T DK 0858345 T3 DK0858345 T3 DK 0858345T3
Authority
DK
Denmark
Prior art keywords
muteins
cytokines
immunogens
wild
type cytokines
Prior art date
Application number
DK96930345T
Other languages
Danish (da)
English (en)
Inventor
Gennaro Ciliberto
Rocco Savino
Riccardo Cortese
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Application granted granted Critical
Publication of DK0858345T3 publication Critical patent/DK0858345T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0008Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Noise Elimination (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96930345T 1995-09-01 1996-08-22 Anvendelse af muteiner af vildtypecytokiner som immunogener DK0858345T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95RM000589A IT1277926B1 (it) 1995-09-01 1995-09-01 Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
PCT/IT1996/000164 WO1997009064A1 (en) 1995-09-01 1996-08-22 Use of muteins of wild-type cytokines as immunogens

Publications (1)

Publication Number Publication Date
DK0858345T3 true DK0858345T3 (da) 2003-02-24

Family

ID=11403544

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96930345T DK0858345T3 (da) 1995-09-01 1996-08-22 Anvendelse af muteiner af vildtypecytokiner som immunogener

Country Status (17)

Country Link
US (1) US6706261B1 (it)
EP (1) EP0858345B1 (it)
JP (1) JP3157837B2 (it)
KR (1) KR100279539B1 (it)
CN (1) CN1138562C (it)
AT (1) ATE226446T1 (it)
AU (1) AU703300B2 (it)
CA (1) CA2229045C (it)
DE (1) DE69624498T2 (it)
DK (1) DK0858345T3 (it)
ES (1) ES2183007T3 (it)
HK (1) HK1015708A1 (it)
IT (1) IT1277926B1 (it)
MX (1) MX9801550A (it)
PT (1) PT858345E (it)
RU (1) RU2182014C2 (it)
WO (1) WO1997009064A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR025984A1 (es) * 1999-10-07 2002-12-26 Maxygen Aps Polipeptidos oligomericos de cadena simple
FR2812813B1 (fr) * 2000-08-09 2004-11-26 Neovacs Utilisation d'immunogenes pour traiter ou prevenir au sein des tumeurs malignes les dereglements immunitaires induits par des facteurs extracellulaires
IL161672A0 (en) * 2004-04-29 2004-09-27 Yeda Res & Dev Compositions and methods for therapy of chemotherapy-induced neuropathy
FR2978964B1 (fr) 2011-08-09 2015-02-20 Conservatoire Nat Arts Composition vaccinale anti-il-6
WO2015024148A1 (zh) * 2013-08-23 2015-02-26 中国科学院微生物研究所 异源动物细胞因子突变体疫苗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677654B1 (fr) 1991-06-17 1995-11-17 Pasteur Merieux Serums Vacc Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.
US5338833A (en) * 1992-07-23 1994-08-16 The University Of North Carolina At Chapel Hill Carboxy terminal IL-6 muteins
IT1263022B (it) * 1992-11-06 1996-07-23 Angeletti P Ist Richerche Bio Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
IT1261787B (it) * 1993-06-23 1996-06-03 Angeletti P Ist Richerche Bio Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130.
WO1997010338A1 (en) 1995-09-12 1997-03-20 Chiron Corporation Improved interleukin-6 receptor antagonist

Also Published As

Publication number Publication date
AU703300B2 (en) 1999-03-25
MX9801550A (es) 1998-05-31
KR19990044321A (ko) 1999-06-25
ITRM950589A0 (it) 1995-09-01
CN1138562C (zh) 2004-02-18
JP3157837B2 (ja) 2001-04-16
ES2183007T3 (es) 2003-03-16
ATE226446T1 (de) 2002-11-15
DE69624498D1 (de) 2002-11-28
EP0858345A1 (en) 1998-08-19
AU6942896A (en) 1997-03-27
KR100279539B1 (ko) 2001-02-01
RU2182014C2 (ru) 2002-05-10
DE69624498T2 (de) 2003-06-18
US6706261B1 (en) 2004-03-16
JPH10511111A (ja) 1998-10-27
CA2229045C (en) 2005-10-25
CN1198098A (zh) 1998-11-04
EP0858345B1 (en) 2002-10-23
WO1997009064A1 (en) 1997-03-13
CA2229045A1 (en) 1997-03-13
IT1277926B1 (it) 1997-11-12
HK1015708A1 (en) 1999-10-22
PT858345E (pt) 2003-02-28
ITRM950589A1 (it) 1997-03-01

Similar Documents

Publication Publication Date Title
FR2677654B1 (fr) Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
ATE271063T1 (de) Purin-l-nukleoside, deren analoga und verwendungen
FI970799A0 (fi) Mutanttientoroksiini, joka on tehokas ei-toksinen oraalinen adjuvantti
CY1111912T1 (el) Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
AR008799A1 (es) Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
DK0909556T3 (da) Rosaceae-ekstrakt som bradykininantagonist
ATE249835T1 (de) Immunoregulator
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
DK0858345T3 (da) Anvendelse af muteiner af vildtypecytokiner som immunogener
ATE515258T1 (de) Mukosales verabreichungssytem
BR9815404A (pt) Composição adjuvante para estimular uma eficiente resposta imunológica a uma substância antigênica, vacina para administração a um animal, processo para estimular uma resposta imunológica eficaz em um animal a uma substância antigênica, e, uso da composição adjuvante.
DK0787135T3 (da) Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
EE9800315A (et) Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
BRPI0414073A (pt) método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo
DK1227826T3 (da) Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
DK1156795T3 (da) Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens
ITRM910003A1 (it) Estratto idroalcolico di erbe e piante medicinali per la cura di: tendiniti-nevriti- sciatalgie-dolori reumatici, articolari, cervicali torcicolli.
ATE145335T1 (de) Kreuzreaktive immunisierung gegen influenza
RU96116250A (ru) Штамм pestivirus, используемый для изготовления лапинизированной вирус вакцины против классической чумы свиней